Electrochemical treatment of localized tumors with direct current

Authors

C. K. Chou, City of Hope National Med Center
N. Vora, City of Hope National Med Center
J. R. Li, City of Hope National Med Center
W. Wang, City of Hope National Med Center
Y. Yen, City of Hope National Med Center
R. L. Ren, City of Hope National Med Center
J. A. McDougall, City of Hope National Med Center
C. Staud, City of Hope National Med Center
B. S. Zhou, City of Hope National Med Center
L. Weiss, City of Hope National Med Center

Abstract

To develop cancer electrochemical treatment (ECT) in the United States, we have conducted basic studies and started a Phase I clinical trial. Our in vivo preliminary results indicate that ECT is effective on RIF-1 mouse tumor and rat fibrosarcomas. In the in vitro study ECT clearly demonstrated dose-dependent human oral carcinoma KB cell growth inhibition by colony-forming assay. We have started an animal study to resolve the ECT methodological problems for rat breast cancer. Meanwhile, we began a clinical trial treating patients with recurrent superficial measurable malignant tumors. Our goal is to make ECT a useful alternative method for treating localized tumors.

Publication Title

Proceedings of the International Conference on Bioelectromagnetism

Recommended Citation

Chou, C., Vora, N., Li, J., Wang, W., Yen, Y., Ren, R., McDougall, J., Staud, C., Zhou, B., & Weiss, L. (1998). Electrochemical treatment of localized tumors with direct current. Proceedings of the International Conference on Bioelectromagnetism, 19-20. Retrieved from https://digitalcommons.memphis.edu/facpubs/18539